HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Figures and Tables All Versions of this Article: 102/2/1254    most recent 00346.2009v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Chisari, M. Articles by Mennerick, S. PubMed PubMed Citation Articles by Chisari, M. Articles by Mennerick, S.

The Influence of Neuroactive Steroid Lipophilicity on GABA_A Receptor Modulation: Evidence for a Low-Affinity Interaction

¹Departments of Psychiatry, ²Developmental Biology, ³Neurology, and ⁴Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri

Submitted 17 April 2009; accepted in final form 16 June 2009

Anesthetic steroids with actions at -aminobutyric acid type A receptors (GABA_ARs) may access transmembrane domain binding site(s) directly from the plasma cell membrane. Accordingly, the effective concentration in lipid phase and the ability of the steroid to meet pharmacophore requirements for activity will both contribute to observed steady-state potency. Furthermore, onset and offset of receptor effects may be rate limited by lipid partitioning. Here we show that several GABA-active steroids, including naturally occurring neurosteroids, of different lipophilicity differ in kinetics and potency at GABA_ARs. The hydrophobicity ranking predicted relative potency of GABA_AR potentiation and predicted current offset kinetics. Kinetic offset differences among steroids were largely eliminated by -cyclodextrin, a scavenger of unbound steroid, suggesting that affinity differences among the analogues are dwarfed by the contributions of nonspecific accumulation. A 7-nitrobenz-2-oxa-1,3-diazole (NBD)–tagged fluorescent analogue of the low-lipophilicity alphaxalone (C17-NBD-alphaxalone) exhibited faster nonspecific accumulation and departitioning than those of a fluorescent analogue of the high-lipophilicity (3,5)-3-hydroxypregnan-20-one (C17-NBD-35A). These differences were paralleled by differences in potentiation of GABA_AR function. The enantiomer of C17-NBD-35A, which does not satisfy pharmacophore requirements for steroid potentiation, exhibited identical fluorescence kinetics and distribution to C17-NBD-35A, but was inactive at GABA_ARs. Simple simulations supported our major findings, which suggest that neurosteroid binding affinity is low. Therefore both specific (e.g., fulfilling pharmacophore requirements) and nonspecific (e.g., lipid solubility) properties contribute to the potency and longevity of anesthetic steroid action.